SurGenTec Achieves Groundbreaking Approval for OsteoFlo® HydroFiber™

SurGenTec has achieved a key milestone with the FDA 510(k) clearance of its latest innovation, OsteoFlo HydroFiber. This approval recognises the product as a stand-alone bone graft solution, comparable to autograft, for use in spinal surgeries. It is designed for procedures such as interbody fusion cages, disc spaces, and posterolateral fusions.

OsteoFlo HydroFiber incorporates Web Interlace Technology, which suspends particles within its fibres. This feature helps prevent graft migration while ensuring optimal cohesion and flowability.

The product also utilises hydrophilic bonds and specialised fibres that absorb saline, blood, or bone marrow aspirate, creating a strong platform to support the healing process.

By offering a synthetic alternative, this innovation marks a significant advancement in orthopaedic and spinal surgery, providing surgeons with a reliable bone graft solution that may improve patient recovery.

The product is also compatible with the Graftgun, SurGenTec’s flagship delivery device, allowing for efficient backfilling of interbody cages. This method is an improvement over traditional funnel techniques, enhancing precision and ease of use during procedures.

OsteoFlo HydroFiber presents a modern alternative to human tissue grafts, reducing risks associated with allografts, including donor variability, disease transmission, and storage challenges.

By eliminating the need for autograft harvesting, the product helps shorten surgical time and minimises post-operative discomfort, potentially leading to improved patient outcomes.

This synthetic bone graft is designed to be customisable, allowing surgeons to adapt it to different anatomical structures and procedures.

Its fibre-based composition ensures a familiar handling experience for medical professionals while offering a safer, synthetic option to support bone healing.

SurGenTec continues to focus on innovation, bringing forward solutions that enhance both surgical efficiency and patient recovery.